{"name":"Doximity","slug":"doximity","ticker":"DOCS","exchange":"NYSE","domain":"doximity.com","description":"Doximity is an online networking service for medical professionals. Launched in 2010, the platform offers its members curated medical news, telehealth tools, and case collaboration.","hq":"San Francisco, CA","founded":0,"employees":"830","ceo":"Jeff Tangney","sector":"Healthcare IT / Digital Health","stockPrice":17.52,"stockChange":-5.87,"stockChangePercent":-25.1,"marketCap":"$3.3B","metrics":{"revenue":637779008,"revenueGrowth":9.8,"grossMargin":89.7,"rdSpend":93038000,"netIncome":223185000,"cash":735126016,"dividendYield":0,"peRatio":14.7,"fiscalYear":"FY2025"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2023-02-23","type":"earnings","headline":"Doximity Reports Fourth Quarter and Full Year 2022 Financial Results","summary":"Doximity reported revenue of $1.1 billion for the fourth quarter and $4.3 billion for the full year 2022.","drugName":"","sentiment":"positive"},{"date":"2022-08-11","type":"deal","headline":"Doximity Acquires CloudCME","summary":"Doximity acquired CloudCME, a provider of continuing medical education (CME) content and services.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxPeUhGN21aZ0RHOFQxekpoSkFUNm44Rm5SRjBFakplTmVzLUExd2JoODQzTHl5RGstSjlQd1lScUxyanVjRkZOZmtyMWpxTG1qaDJ3azdDQzRod2FLNDFOUmU5QmwwcXpmVmg2R0R4dFVTYUI5emNXcXdyYXgwVzE4V1FiZUdXQUl1bzVWa2k2QkM4MmJJZ09hcg?oc=5","date":"2026-04-06","type":"pipeline","source":"TradingView","summary":"Doximity: Clinician Network Leader - TradingView","headline":"Doximity: Clinician Network Leader","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2AFBVV95cUxOWjM3QjdESzJrS1M3enRISlhrTWRGa3NrR3dISWdrdXpENEc4Qm14TVRBaGIwSjhnRUYzLWN1bVBMUnZ1WTNvOVlyek01VFBMN1cyNHRrcU9vay1oYjdKbl9SdXdwRVZRNjZoZ2pTRnpCc3U0U1NTelQwbUFaTlZaUGZKWlJQaER0U2djUDZVZk9KejRnQ2pCVlRHckxneWRpNUd3M05rejZLNmYyTG00RmpzXzJ0TU92X3RYbjRyLWh0VW5xTGd5cE4xYldPYUxCQ0dDVnBIN3k?oc=5","date":"2026-03-30","type":"pipeline","source":"Sahm","summary":"Does Doximity’s (DOCS) Scale With Physicians and Cash Flow Redefine Its Healthcare Tech Moat? - Sahm","headline":"Does Doximity’s (DOCS) Scale With Physicians and Cash Flow Redefine Its Healthcare Tech Moat?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxNd0w3U2NFcDBwcHNlR2xGd2NrUjlNRm5saHdjQjRmdjRBT0Z4akljUHdkQjhrWlNIRTNpc3UwRTNPSXA4WGJKcWpPNVBKUWd4RFJvSF9aOHVzcXFGVG8xTUdDb09BZEgzcWhLVklwa1hKYU95NUpnelZPOWVNRm4wcDZJSFRVZUZmUlV0R0o5c0R5ek5Vd0E?oc=5","date":"2026-03-10","type":"pipeline","source":"TIKR.com","summary":"Doximity Stock is Down 75% From Its Highs. Do Analysts See Recovery? - TIKR.com","headline":"Doximity Stock is Down 75% From Its Highs. Do Analysts See Recovery?","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-02-28","type":"pipeline","source":"simplywall.st","summary":"Doximity CEO ViVE 2026 Talk Puts AI And Pharma Story In Focus - simplywall.st","headline":"Doximity CEO ViVE 2026 Talk Puts AI And Pharma Story In Focus","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxQcm5nd1VFNmM4Mzk1bnJtNGNpdmNCWTAzR0twWTJ1UUtaQk5pXzNHbjJjbVoyQjBzUk9WV2FJdGhjS0I4c1lwOEJkR1Z1VjBuOXJMaF9SVHZ6TjNwTWRla0UyR1NCcUhwelFLOTZ6R1FZRFd1QTRqWU9VVkJQdGt4YXVKcUlrQVp6bGc0aXhIdUI0NXJpNkxfVVRvU2RWLTVN?oc=5","date":"2026-02-19","type":"deal","source":"TIKR.com","summary":"Doximity Stock: Why Analysts Are Signaling a Buy After a 67% Drop Last Year - TIKR.com","headline":"Doximity Stock: Why Analysts Are Signaling a Buy After a 67% Drop Last Year","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTE41anY4LUNKS1lURjlRTVcwTnJQWmJia1l3QVAxZWxmYzBhbnZVODQxOW1YY2JhbXpocmdhdlRIZzd3MkNvWDNiVm5fQ0pidXhpUzhOQk1nODlfR21ZM3V3SkxsLU1BTHVwT2RSckYtWFpMU085ZTlB?oc=5","date":"2026-02-14","type":"earnings","source":"Yahoo Finance","summary":"Doximity (DOCS) Is Down 9.8% After Big Buybacks and Mixed Q3 Signals Has The Bull Case Changed? - Yahoo Finance","headline":"Doximity (DOCS) Is Down 9.8% After Big Buybacks and Mixed Q3 Signals Has The Bull Case Changed?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxNRGl0LUlwOFZyVXNadmZ2TUNlSDgwSERuV2l4X0sxSktQak4waHhrMWVCN18tV2NSRVVIWGVuSnF4WXJOMkt4bDBKdml3ejhYbmI0eERuV3dlQUFtbVJPSTRVZEVYbFkyb0R4a1BEd2dzdVM0Z1Y2MVZPSF84VFJMYXpmVG9jaUZLekdjRFJwbHNoRVl3ZXlZ?oc=5","date":"2026-02-12","type":"earnings","source":"Finviz","summary":"5 Revealing Analyst Questions From Doximity's Q4 Earnings Call - Finviz","headline":"5 Revealing Analyst Questions From Doximity's Q4 Earnings Call","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizwFBVV95cUxNZk1yLTR2U2QySlhrZlRwVFpKYVM0LU9RUnowR2k1T3hpS0FoaXppUVhTSnV6elREQ3VLeFY3eGdFNldRR2txSkVEdFh6U2E4NzFpcW1HUEFsUUxzcnZFN2l6UkNldV9qT1VDRDhTN0Z4Z3RKT2JmZWdhNkNWX1dOdi04ejc0dFFjcnR4X3lnVXZIRlJuYk1aaFI0ZU1uNHctQm5HQ0lZSU5sLWo5ek5RVGwxbG5MQlJNQlRXeHVnVThEQjVQdk5lZ1R5dU81VGc?oc=5","date":"2026-02-10","type":"pipeline","source":"Investing.com","summary":"Mizuho lowers Doximity stock price target to $34 on pharma marketing delays - Investing.com","headline":"Mizuho lowers Doximity stock price target to $34 on pharma marketing delays","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2AFBVV95cUxNSjdJbm9OZ2h2ZHozcGMzaWZpbGs0QmJQeF9PYUdmUE9HS2ZxZWJ3OTFiQkxUU1RyTklTV1BldE1Vd0pMc1l5SzhlemJ2OFhCOVFZS2J2eGFnaVZYNlcwYnZQTUR2d0pIek5jcWlaZlYxajEtdFZkSkhESnFMRlVXNjNPbWRzT085aHZ6X1hYdm5QMW9UUy1YeFFqQVlranJWdjc4Yk1ZdjFRX2p3V01yX3BSdFBtVFdHUGVFZVdjMWRjQTVqbDJVbUxoanFHQm9JcWxQMTJYVWg?oc=5","date":"2026-02-06","type":"pipeline","source":"FinancialContent","summary":"Doximity (DOCS) Stock Plummets 17% on Weak Guidance and AI Cost Surges - FinancialContent","headline":"Doximity (DOCS) Stock Plummets 17% on Weak Guidance and AI Cost Surges","sentiment":"neutral"},{"date":"2026-02-05","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: 10-Q","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"date":"2026-02-05","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2025-12-30","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxOaV9MODRRWTBOWDg0dHhDUVpWVnVZaEFBc056TW1uQko4UW8tdm52OW1kVW9tdE9MSy1XLXFyQldKNE02S1FyaDN6WXJDMW1IRkk1T2tSRnc0TTdhSm1Zb1VHNWNMekh4X1dKUzBoczhtMndpUEI1UEZMQ2M0cGo3cFBMc3JlZXhCR2hQZmxua2pFOXRzZlNfc3ZYQlo?oc=5","date":"2025-12-07","type":"pipeline","source":"Seeking Alpha","summary":"Doximity: Elite Margins, AI Growth, And An Attractive Multiple (NYSE:DOCS) - Seeking Alpha","headline":"Doximity: Elite Margins, AI Growth, And An Attractive Multiple (NYSE:DOCS)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTE9EaEVFNUEwZm1qQVdjS1lPVEo5U2J5d0FTeXdYejFkanhqaTdtWkcxOWdEV1c3Y2ZtLS14LU5nZXRyNWExajZJc2dSMmdyckpJVzRFTi1nTkRlQjBzaUI4TjF2S1dLS1VuRnAxVEtHWWZORzJYTFlSMWxDZEUzZw?oc=5","date":"2025-10-28","type":"pipeline","source":"Yahoo Finance","summary":"Did Pharma Ad Budget Shifts Just Reshape Doximity's (DOCS) Digital Health Advantage? - Yahoo Finance","headline":"Did Pharma Ad Budget Shifts Just Reshape Doximity's (DOCS) Digital Health Advantage?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxOLVk5eVVqX1c2eUlnRnY2U1ZyRnUyZzBPQnlnb1VvM2daSTJLeF9KRUFWb21nR05lX0FHZnk1cUR2QnZZNDB1RXZIUlRmMlJDUmtDTnlwOFhpTHU3MDVvYzVEOWpuelREZDRqVXVzQ2xpLUprM2ItYjZFUE0zamU3am05b2xlYWtVZFp5VUtSdEhYRDNaVkczdGFDT2M4TGJsMTNPM0pQWFdXaUJISlVz?oc=5","date":"2025-10-10","type":"pipeline","source":"StockStory","summary":"Why Doximity (DOCS) Shares Are Trading Lower Today - StockStory","headline":"Why Doximity (DOCS) Shares Are Trading Lower Today","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Teladoc Health (TDOC)","American Well (AMWL)","Change Healthcare (CHNG)"],"therapeuticFocus":["Healthcare IT","Digital Health"],"financials":{"source":"sec_edgar+yahoo","revenue":570399000,"revenuePeriod":"2025-03-31","revenueHistory":[{"value":570399000,"period":"2025-03-31"},{"value":475422000,"period":"2024-03-31"},{"value":475422000,"period":"2024-03-31"},{"value":419052000,"period":"2023-03-31"},{"value":419052000,"period":"2023-03-31"}],"grossProfit":514525000,"grossProfitHistory":[{"period":"2025-03-31","value":514525000},{"period":"2024-03-31","value":424753000},{"period":"2023-03-31","value":365562000},{"period":"2022-03-31","value":303761000}],"rdSpend":93038000,"rdSpendHistory":[{"period":"2025-03-31","value":93038000},{"period":"2024-03-31","value":81983000},{"period":"2023-03-31","value":80186000},{"period":"2022-03-31","value":62350000}],"sgaSpend":191383000,"operatingIncome":230104000,"operatingIncomeHistory":[{"period":"2025-03-31","value":230104000},{"period":"2024-03-31","value":171814000},{"period":"2023-03-31","value":125108000},{"period":"2022-03-31","value":113536000}],"netIncome":223185000,"netIncomeHistory":[{"period":"2025-03-31","value":223185000},{"period":"2024-03-31","value":147582000},{"period":"2023-03-31","value":112818000},{"period":"2022-03-31","value":154783000}],"eps":1.11,"epsHistory":[{"period":"2025-03-31","value":1.11},{"period":"2024-03-31","value":0.72},{"period":"2023-03-31","value":0.53},{"period":"2022-03-31","value":0.7}],"cash":209614000,"cashHistory":[{"period":"2025-03-31","value":209614000},{"period":"2024-03-31","value":96785000},{"period":"2023-03-31","value":158027000},{"period":"2022-03-31","value":112809000}],"totalAssets":1264309000,"totalLiabilities":181684000,"totalDebt":12396000,"equity":1082625000,"operatingCashflow":273265000,"operatingCashflowHistory":[{"period":"2025-03-31","value":273265000},{"period":"2024-03-31","value":184096000},{"period":"2023-03-31","value":179602000},{"period":"2022-03-31","value":126575000}],"capex":-6525000,"capexHistory":[{"period":"2025-03-31","value":-6525000},{"period":"2024-03-31","value":-5801000},{"period":"2023-03-31","value":-6184000},{"period":"2022-03-31","value":-5697000}],"freeCashflow":266740000,"dividendsPaid":null,"buybacks":-120293000,"employees":830,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[{"sga":59861000,"ebit":71896000,"ebitda":75885000,"period":"2025-12-31","revenue":185053000,"epsBasic":0.33,"netIncome":61558000,"rdExpense":34595000,"epsDiluted":0.31,"grossProfit":166352000,"operatingIncome":71896000},{"sga":58217000,"ebit":63681000,"ebitda":67150000,"period":"2025-09-30","revenue":168525000,"epsBasic":0.33,"netIncome":62059000,"rdExpense":30202000,"epsDiluted":0.31,"grossProfit":152100000,"operatingIncome":63681000},{"sga":48804000,"ebit":54517000,"ebitda":57311000,"period":"2025-06-30","revenue":145913000,"epsBasic":0.28,"netIncome":53320000,"rdExpense":26799000,"epsDiluted":0.27,"grossProfit":130120000,"operatingIncome":54517000},{"sga":50338000,"ebit":48680000,"ebitda":51509000,"period":"2025-03-31","revenue":138288000,"epsBasic":0.33,"netIncome":62458000,"rdExpense":24803000,"epsDiluted":0.31,"grossProfit":123821000,"operatingIncome":48680000},{"sga":52076000,"ebit":79925000,"ebitda":82580000,"period":"2024-12-31","revenue":168603000,"epsBasic":0.4,"netIncome":75196000,"rdExpense":22421000,"epsDiluted":0.37,"grossProfit":154422000,"operatingIncome":79925000},{"sga":null,"ebit":null,"ebitda":null,"period":"2024-09-30","revenue":null,"epsBasic":null,"netIncome":null,"rdExpense":null,"epsDiluted":null,"grossProfit":null,"operatingIncome":null}]},"ciks":null,"lastFiledAt":null},"yahoo":{"currentPrice":17.52,"previousClose":23.39,"fiftyTwoWeekHigh":76.51,"fiftyTwoWeekLow":17.15,"fiftyTwoWeekRange":"17.15 - 76.51","fiftyDayAverage":24.28,"twoHundredDayAverage":46.15,"beta":1.35,"enterpriseValue":3595908608,"forwardPE":11,"priceToBook":3.31,"priceToSales":5.17,"enterpriseToRevenue":5.64,"enterpriseToEbitda":14.65,"pegRatio":0.71,"ebitda":245460000,"ebitdaMargin":38.5,"freeCashflow":213631376,"operatingCashflow":315423008,"totalDebt":10692000,"debtToEquity":1.1,"currentRatio":6.63,"returnOnAssets":12.8,"returnOnEquity":23.8,"analystRating":"1.8 - Buy","recommendationKey":"buy","numberOfAnalysts":22,"targetMeanPrice":37.77,"targetHighPrice":55,"targetLowPrice":25,"dividendRate":0,"payoutRatio":0,"fiveYearAvgDividendYield":0,"exDividendDate":0,"insiderHeldPercent":2.5,"institutionHeldPercent":91.9,"sharesOutstanding":133811547,"floatShares":130570762,"sharesShort":16999173,"shortRatio":5.36,"shortPercentOfFloat":9.2,"epsTrailing":1.19,"epsForward":1.59,"revenuePerShare":3.4,"bookValue":5.29,"officers":[{"age":52,"name":"Mr. Jeffrey A. Tangney","title":"Co-Founder, CEO & Chairperson"},{"age":41,"name":"Dr. Nathan  Gross M.D.","title":"Advisor & Co-Founder"},{"age":null,"name":"Ms. Shari  Buck","title":"Co-founder and SVP People & Ops"},{"age":null,"name":"Mr. Siddharth  Sitaram","title":"Chief Accounting Officer and Interim Principal Financial & Accounting Officer"},{"age":null,"name":"Mr. Jey  Balachandran","title":"Chief Technology Officer"},{"age":null,"name":"Mr. Perry Scott Gold","title":"Head of Investor Relations"},{"age":null,"name":"John  Vaughan","title":"General Counsel, Corporate Secretary & Chief Compliance Officer"},{"age":null,"name":"Mr. Bruno  Miranda","title":"Senior Vice President of Engineering"}],"industry":"Health Information Services","irWebsite":"","website":"https://www.doximity.com","phone":"650 549 4330"}}